|
Volumn 37, Issue 3, 2007, Pages 199-202
|
Neurological aspects of the clinical features, pathophysiology, and corrections of impairments in attention deficit hyperactivity disorder
a b |
Author keywords
Attention deficit hyperactivity disorder; MAGNE B6; Pathophysiology
|
Indexed keywords
ADENOSINE TRIPHOSPHATASE (MAGNESIUM);
MAGNE B6;
MAGNESIUM;
MAGNESIUM DERIVATIVE;
MAGNESIUM LACTATE;
MULTIVITAMIN;
PYRIDOXINE;
SANA SOL;
UNCLASSIFIED DRUG;
ABSENCE OF SIDE EFFECTS;
ARTICLE;
ATTENTION DEFICIT DISORDER;
BIOCHEMISTRY;
CENTRAL NERVOUS SYSTEM;
CENTRAL NERVOUS SYSTEM DISEASE;
CHILD;
CLINICAL ASSESSMENT;
CLINICAL FEATURE;
COHORT ANALYSIS;
CONTROLLED STUDY;
DISEASE COURSE;
ELECTROENCEPHALOGRAPHY;
EMOTIONAL DISORDER;
ENZYME ACTIVITY;
ERYTHROCYTE;
FEMALE;
GENETIC PREDISPOSITION;
GENETIC RISK;
HUMAN;
LOW DRUG DOSE;
MAGNESIUM BLOOD LEVEL;
MAJOR CLINICAL STUDY;
MALE;
MENTAL DISEASE;
MOTOR DYSFUNCTION;
NEUROLOGIC DISEASE;
NEUROPSYCHOLOGICAL TEST;
PATHOPHYSIOLOGY;
PREVALENCE;
RISK ASSESSMENT;
RISK FACTOR;
RUSSIAN FEDERATION;
SEX DIFFERENCE;
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;
CA(2+) MG(2+)-ATPASE;
CHILD;
COGNITION DISORDERS;
COHORT STUDIES;
ELECTROENCEPHALOGRAPHY;
EMOTIONS;
FEMALE;
HUMANS;
MAGNESIUM;
MALE;
NERVOUS SYSTEM DISEASES;
NEUROPSYCHOLOGICAL TESTS;
RUSSIA;
VITAMIN B 6;
|
EID: 33947360793
PISSN: 00970549
EISSN: 1573899X
Source Type: Journal
DOI: 10.1007/s11055-007-0001-z Document Type: Article |
Times cited : (15)
|
References (19)
|